Javeri Fiscal Services Ltd.

About Javeri

Equity

Derivatives

Mutual Funds

IPO

Corporate Info

Research

Contact Us

Corporate Info

Smart Quotes

Company Background

Board of Directors

Balance Sheet

Profit & Loss

Peer Comparison

Cash Flow

Shareholdings Pattern

Quarterly Results

Share Price

Deliverable Volume

Historical Volume

MF Holdings

Financial Ratios

Directors Report

Price Charts

Beta Analysis

Board Meetings

Corporate Announcements

Book Closure

Bonus

Company News

Dividend Details

Bulk Deals

Insider Trading

Advanced Chart

HOME > CORPORATE INFO > SMART QUOTES

Smart Quotes

Dr. Reddy's Laboratories Ltd.

Industry : Pharmaceuticals & Drugs

BSE Code	500124
ISIN Demat	INE089A01031
Book Value	379.50

NSE Code	DRREDDY
Dividend Yield %	0.63
Market Cap	1052815.36

P/E	15.27
EPS	82.59
Face Value	1


	BSE		NSE

05-Sep-2025 12:36

Last Price	1260.20
Net Change	6.8
% Change	0.54%
Prev.Close	1253.40
Open	1249.55
High	1268.95
Low	1249.55
Volume	19051

Last Price	1260.20
Net Change	7.2
% Change	0.57%
Prev.Close	1253.00
Open	1254.30
High	1269.30
Low	1253.60
Volume	301032

Value	24008070.2
Best Buy	1259.45
Best Sell	1260.15
Best Quantity	91
Sell Quantity	1
Today's Range	1268.95
52-Week High	1404.60
52-Week Low	1025.90

Value	379360526.4
Best Buy	1260.20
Best Sell	1260.30
Best Quantity	30
Sell Quantity	13
Today's Range	1269.30
52-Week High	1405.90
52-Week Low	1020.00

Open Price	1260.80
High Price	1269.40
Low Price	1256.00
Last Price	1259.00
Prev Close	1255.20
Change	3.80
% Change	0.30 %

Average Price	1262.66
Underlying Value	1260.20
Number of contracts traded	1012
Turnover in Rs. Lakhs	7986
Open Interest	12202500.00
Change in O I	-43130.00
% Change in O I	-0.35 %

Today

|

1W

|

1M

|

1Y

You need to upgrade your Flash Player

Best Bid

Best Offer

Quantity	91
Price	1259.45

Quantity	1
Price	1260.15

Best Bid

Best Offer

Quantity	30
Price	1260.20

Quantity	13
Price	1260.30

Best Bid

Best Offer

Quantity	625
Price	1258.6

Quantity	625
Price	1259.7

Holding Details

Latest Corporate Events

Bonus

1 : 1

28-Aug-06

Book Closure

17-Jul-24

19-Jul-24

Dividend

800 %

10-Jul-25

Company News

20-08-2025

Dr Reddys Laboratories in...

20-08-2025

Dr. Reddy’s Laboratories ...

11-08-2025

Dr. Reddy's Laboratories ...

11-08-2025

Dr. Reddy's Laboratories ...

26-07-2025

Dr. Reddy's makes investm...

24-07-2025

Dr Reddy's Laboratories r...

24-07-2025

Dr Reddy's Laboratories m...

Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores

Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: Click Here.